Veryan was founded in 2005 as the result of a technology spin out from Imperial College, London, based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering Imperial College) on the link between vessel geometry, blood flow mechanics and vascular disease.


Veryan used its understanding of swirling flow and its expertise in research and development to design, develop and patent the highly innovative three-dimensional (3D), nitinol (nickel-titanium alloy) BioMimics 3D Vascular Stent System.

Part of Otsuka Medical Devices

Veryan became an Otsuka Medical Devices company in 2018.

With our long track record of R&D, clinical, regulatory and commercial achievements and the support and endorsement of notable, international KOLs, we bring real, practical, unique solutions to challenges that physicians face daily; delivering intelligent design and improved clinical outcomes.

More From Veryan


At Veryan, we look for entrepreneurial people who are ready to make a difference.

News, Press and Events

Read about our latest News, Press Releases and Events.

Veryan people

Veryan has an industry leading Executive team with deep sector expertise, a proven track record and over 200 years’ experience in Healthcare.